Boswellia Side Effects in Dogs: What the Label Won't Tell You

By Joyce Gerardi, DVM, CVA, CVCH, CVFT, MSTCVM

✓ Medically reviewed by Joyce Gerardi, DVM, CVA, CVCH, CVFT, MSTCVM — August 25, 2026 For general education — not a substitute for veterinary care.

Joint supplements · August 28, 2026 · 6 min read

Boswellia is one of the gentler joint herbs on my shelf, but "gentle" still means reading the label and doing the dose math before it goes in the bowl.

I still remember the phone call from a client whose ten-year-old Weimaraner, Otto, had started on a boswellia chew she’d bought after reading a forum thread. Otto weighed 78 pounds, had early hip changes on radiographs, and had been slowing down on the stairs that fall. Two days in, he had soft stool and gas that made the whole car ride to his recheck unpleasant. Nothing dangerous — but it was enough to make her stop the supplement cold and call me, worried she’d done something wrong. She hadn’t. She’d just given him more than his weight called for, because the label’s “one chew per dog” dosing didn’t account for the fact that Otto was nearly double the size of the toy breed used on the packaging photo.

That’s the boswellia story I tell most often, and it sets the verdict up front: boswellia serrata is one of the better-tolerated joint herbs available for dogs, and the documented side effects are mild and dose-related — mostly gastrointestinal — but the dosing math matters more than most owners realize, and it deserves the same label-reading scrutiny I’d apply to any other supplement on the shelf.

What actually shows up as a side effect

The short list, pulled from clinical and case-report sources, is short on purpose. VCA Animal Hospitals notes that boswellia is generally well tolerated in dogs, with gastrointestinal upset — soft stool, gas, occasional vomiting — as the most commonly reported issue, and that these effects tend to track with dose. That lines up with what I see clinically: it’s rarely an all-or-nothing reaction. It’s usually a dog whose stool loosens for a few days until the dose is adjusted downward or split with a meal.

Allergic reactions are possible with any botanical, though they aren’t common with boswellia specifically. If a dog develops itching, skin irritation, or facial swelling after starting a new supplement, that’s a reason to stop and call your vet — regardless of which herb or ingredient is the suspect.

Where the dosing research actually comes from

The clinical study most often cited for canine boswellia use is a 2004 trial that dosed a Boswellia resin extract at 400 mg per 10 kg of body weight daily for six weeks in dogs with inflammatory joint and spinal disease, reported on PubMed. That’s roughly 40 mg/kg — worth doing the arithmetic on before you trust a flat “one chew fits all” label claim. A more recent scoping review in Animals, indexed by MDPI, looked at both undenatured type II collagen and Boswellia serrata for canine osteoarthritis and joint support, and it’s blunt about the state of the evidence: dosing and formulation standards across commercial boswellia products still aren’t consistent, which is exactly the gap that lets under- or over-dosing happen at the consumer level.

That inconsistency is the real risk, more than the herb itself. Boswellic acid content varies by extraction method and standardization, and a supplement’s label doesn’t always spell out the percentage of AKBA (a key active boswellic acid) it’s actually delivering. Without that number, you’re dosing blind.

A second dog, a different lesson

A few months after Otto, I worked with a 14-pound dachshund named Biscuit who’d been on a low dose of a combination chew that included boswellia alongside glucosamine and green-lipped mussel. Biscuit’s owner was doing everything right — she’d weighed him, split the recommended dose, and given it with his evening meal. He tolerated it well for months, with no GI signs at all. The difference between Otto and Biscuit wasn’t the herb; it was that Biscuit’s owner had matched the dose to his actual weight from day one, and started low. I bring this up because it’s tempting to treat “boswellia caused side effects” and “boswellia is safe” as contradictory data points. They’re not. They’re the same ingredient behaving exactly as dose-response pharmacology predicts.

In my own casework, situating an herb like boswellia inside the whole-patient picture matters more than any single ingredient claim. A dog on NSAIDs for arthritis, a dog with a sensitive gut, and a healthy middle-aged dog starting joint support for the first time are three different risk profiles wearing the same diagnosis. I don’t treat boswellia as a stand-alone fix — I look at what else is in the bowl, what other medications are on board, and whether the dose on the label actually matches the dog in front of me.

Drug interactions worth knowing

Boswellia’s anti-inflammatory action means it can theoretically add to the effects of NSAIDs or other anti-inflammatory medications, increasing the risk of GI upset when combined. This isn’t a reason to avoid pairing them under veterinary guidance — plenty of arthritic dogs are managed on both — but it is a reason to loop your vet in before stacking a new herbal supplement on top of an existing prescription NSAID, rather than adding it on your own.

How boswellia compares to the more studied joint actives

Boswellia doesn’t have the volume of research behind it that glucosamine and chondroitin do. Glucosamine and chondroitin are among the most studied joint support ingredients for dogs, and chondroitin specifically has been shown to support healthy synovial fluid homeostasis, per a study indexed under DOI 10.3389/fvets.2026.1536366. Separately, glucosamine HCl has been shown in review literature to help prevent experimentally induced cartilage degradation in vitro, per DOI 10.1292/jvms.25-0293. Green-lipped mussel powder has its own inflammation-focused data: research indexed under DOI 10.3390/nu18020215 found that mussel-derived compounds alleviated paw swelling in rats and reduced serum markers of inflammation, including TNF-α and IL-17.

None of that displaces boswellia — it just means boswellia tends to show up as a complementary ingredient in combination formulas rather than the headline active. If you’re comparing full label panels rather than a single ingredient, our best joint supplement for dogs breakdown walks through how we score a full ingredient stack, dose by dose.

The scene that sticks with me

Otto came back for his three-month recheck walking better on the stairs, off the boswellia chew and onto a properly dosed combination product instead, and his owner had learned to read a supplement facts panel the way she’d learned to read his kibble bag years earlier — checking the per-pound math instead of trusting the front-of-package dosing chart. That’s the habit I want every owner to walk away with, not a fear of the herb itself.

If you’re weighing a house brand against a competitor’s boswellia-containing chew, dose transparency and third-party testing are the two things worth checking before purchase. Our side-by-side reads of Boops Pets vs. Natural Dog Company and Boops Pets vs. VetActiv8 show what that label-reading process looks like in practice, ingredient by ingredient. And if you’re building a joint-support plan from scratch rather than comparing two labels, our guide to what actually belongs in a hip and joint scoop covers the ingredient categories worth prioritizing.

Where this is headed

Boswellia research in dogs is still catching up to its popularity — more standardized-extract trials with clear AKBA percentages would settle the dosing question for good. Until then, the safest path is the boring one: weigh your dog, match the dose to the study data rather than the front-of-label chart, start low, and give your vet a heads-up if there’s an NSAID already in the picture. That’s not a hedge. It’s just how a genuinely gentle herb stays gentle.